# Jiangsu Weiming Shiguang Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-weiming-shiguang-biotechnology

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.veminsyn.com
- Total disclosed funding: $14M
- Latest round: Series B (Sep 29, 2025)
- Investors on record: 7

## About

Established in 2021 and based in Beijing, China, Beijing Weiming Shiguang Biotechnology is a medical health company that focuses on research and development of new medical beauty skin care raw materials. The company is mainly involved in the field of medicine, consumption, agriculture and energy. The company founding team is from Tsinghua University and Peking University. The company has partnerships with Peking University, Tsinghua University, Zhejiang University, China Agricultural University, and South China University of Technology. In July 2024, the company changed Headquarters address and Legal name. In May 2025, Weiming Shiguang Biotechnology raised approximately CNY 100 million in series B funding from new investors L'Oreal S.A. and Nice Zhejiang Investment. In September 2025, Jiangsu Weiming Shiguang Biotechnology closed a series B+ funding from new investors Huatai Zijin Investment and Haibang Venture.

The company is main business is research and development of new medical beauty skin care raw materials. The company has three self-developed platform such as SGDesignTM, SGConstructTM and SGManufactureTM. The company generates revenue from researching and developing of new medical beauty skin care raw materials.

The company will use the series B+ funding to deepen the development of its AI technology platform, expand diverse application scenarios for biomaterials, and accelerate its global expansion.

## Funding rounds

- Series B, Sep 29, 2025 — Haibang Venture, Huatai Zijin Investment
- Series A, Oct 18, 2022, $14M — CITIC Capital Holdings, Hony Capital, ZhenFund, Next Capital, Jiangsu Yangtze River International Metallurgical Industrial Park
- Angel, May 21, 2021 — ZhenFund, Next Capital

## Investors

- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Angel, Series A
- Next Capital — Angel, Series A
- CITIC Capital Holdings (https://capitalatlas.ai/funds/citic-capital-holdings) — Series A
- Hony Capital (https://capitalatlas.ai/funds/hony-capital) — Series A
- Jiangsu Yangtze River International Metallurgical Industrial Park — Series A
- Haibang Venture — Series B
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series B